Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Astrazeneca R&d Boston patentsThe following is a sampling of recent Astrazeneca R&d Boston patent applications (USPTO Patent Application #, Patent Title) sorted by month.
March 2008 - Astrazeneca R&d Boston patents
20080076780 - Combination of n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent
20080064691 - Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity
February 2008 - Astrazeneca R&d Boston patents
20080045481 - Novel co-crystal
20080045517 - 6h-thieno[2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh)
20080045521 - Phenylalanine derivatives
January 2008 - Astrazeneca R&d Boston patents
20080027076 - Pyrimidines with tie2 (tek) activity
20080020416 - Enzyme and preparation method
20080021012 - 3-[4-{6-substituted alkanoyl pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
20080009482 - Novel compounds
20080009512 - Tetrahydroquinolones and aza-analogues thereof for use as dpp-iv inhibitors in the treatment of diabetes
20080004302 - Novel compounds
December 2007 - Astrazeneca R&d Boston patents
20070298413 - Topoisomerase modulators assays
20070287703 - Fused pyrimidones useful in the treatment and the prevention of cancer
20070281916 - Substituted isoxazolines and their use as antibacterial agents
November 2007 - Astrazeneca R&d Boston patents
20070275954 - Novel fused heterocycles and uses thereof
20070275982 - Method
20070270384 - Process and intermediate
20070259849 - Azine-carboxamides as anti-cancer agents
October 2007 - Astrazeneca R&d Boston patents
20070249636 - Selected fused heterocyclics and uses thereof
August 2007 - Astrazeneca R&d Boston patents
20070202548 - Screening assay to identify inhibitors of the murd enzyme using an activator-independent murd enzyme
20070185106 - Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
20070185185 - Derivatives of thienopyrrole as gnrh antagonists
July 2007 - Astrazeneca R&d Boston patents
20070172425 - Testing cell cycle regulation effect of a compound using a hollow fibre cell implant
20070167428 - Thienopyrroles as antagonists of gnrh
June 2007 - Astrazeneca R&d Boston patents
20070149560 - Novel fused triazolones and the uses thereof
20070142413 - Pyrazole derivatives as inhibitors of receptor tyrosone kinases
20070135455 - Substituted thieno- and thiazolo- [2,3-d]pyrimidines and [2,3-c]pyridines as inhibitors of tie2
May 2007 - Astrazeneca R&d Boston patents
20070123528 - Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity
20070117138 - Splice variant cannabinoid receptor (cb1b)
April 2007 - Astrazeneca R&d Boston patents
20070092879 - Fluoresence-based dna primase assays
February 2007 - Astrazeneca R&d Boston patents
20070043069 - Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
20070037888 - 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
January 2007 - Astrazeneca R&d Boston patents
20070010556 - Thiophene derivatives as chk 1 inhibitors
December 2006 - Astrazeneca R&d Boston patents
20060287241 - Combination comprising n-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazol-2-y1]pyridine-3-sulphonamide and an lhrh analogue and/or bisphosphonate
20060287379 - Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
20060281666 - Substitute thiophenes and uses therof
November 2006 - Astrazeneca R&d Boston patents
20060270637 - Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents
20060270689 - Novel fused heterocycles and uses thereof
20060270692 - Chemical compounds
20060263298 - Assay
20060264494 - Heterocyclic amide derivatives which process glycogen phorylase inhibitory activity
20060258710 - Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
20060252781 - Fused heterocycles as inhibitors of glutamate racemase(muri)
October 2006 - Astrazeneca R&d Boston patents
20060235067 - 6h-thieno[2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh)
20060223801 - Pyrrol derivatives with antibacterial activity
September 2006 - Astrazeneca R&d Boston patents
20060216774 - Method
20060211760 - Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
20060199966 - Indol-2-amides as glycogen phosphorylase inhibitors
August 2006 - Astrazeneca R&d Boston patents
20060194260 - Screening assays for cannabinoid-ligand-type modulators of gpr55
20060178382 - Chinazoline derivatives as aurora kinase inhibitors
20060173034 - Novel 4-anilinoquinoline-3-carboxamides
July 2006 - Astrazeneca R&d Boston patents
20060166288 - Assay for the screening of compounds acting through erbb-2
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Astrazeneca R&d Boston in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Astrazeneca R&d Boston with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
